About Filgotinib Filgotinib is indicated for the treatment of moderate to severe active rheumatoid arthritis in adults…
About Abrocitinib Abrocitinib is a medication used for the treatment of atopic dermatitis (eczema). It is a Janus kinase inhibitor . In…
About Momelotinib ONE PILL, ONCE DAILY Momelotinib is an anticancer medication used for the treatment of myelofibrosis. It is a Janus…
About Anamorelin Anamorelin (developmental code names ONO-7643, RC-1291, ST-1291), also known as anamorelin hydrochloride (USAN, JAN), is a non-peptide, orally-active, centrally-penetrant, selective agonist of the ghrelin/growth hormone secretagogue…
About Febuxostat Febuxostat is used to lower hyperuricemia (high uric acid in the blood) in patients…
Tofacitinib is used alone or with other medications to treat rheumatoid arthritis (condition in which the body attacks its…
Baricitinib is an orally bioavailable inhibitor of Janus kinases 1 and 2 (JAK1/2), with potential anti-inflammatory,…
Baricitinib is an orally bioavailable inhibitor of Janus kinases 1 and 2 (JAK1/2), with potential anti-inflammatory,…
Ryzneuta® (Efbemalenograstim alfa-vuxw), sold under the brand name 亿立舒® in china, is a leukocyte growth factor used…
Tofidence® (Tocilizumab-bavi) sold under the brand name 施瑞立® in china, is a monoclonal antibody that binds to interlukin-6 receptors and…
Tofacitinib is used alone or with other medications to treat rheumatoid arthritis (condition in which the body attacks…
Upadacitinib is a medication used for the treatment of rheumatoid arthritis, psoriatic arthritis, atopic dermatitis, ulcerative colitis, Crohn's disease, ankylosing spondylitis, and axial spondyloarthritis.Upadacitinib…
What is deucravacitinib used for? Deucravacitinib acts as a highly selective allosteric inhibitor of non-receptor tyrosine-protein kinase…
Ruxolitinib is a medication used for the treatment of intermediate or high-risk myelofibrosis,a type of myeloproliferative neoplasm that affects the bone marrow;…
Medication management Oral administration Lesinurad is used in combination with xanthine oxidase inhibitors such as allopurinol Not recommended for patients…
Baricitinib is an orally bioavailable inhibitor of Janus kinases 1 and 2 (JAK1/2), with potential anti-inflammatory,…